SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cambridge Antibody Technology Group
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: A.J. Mullen who wrote (607)5/15/2006 12:10:03 PM
From: keokalani'nui  Read Replies (2) of 625
 
This was inevitable, but not at all predictable for today or even 2006. I'm kinda cranky myself, being out of a stock I've owned off and on for the better since 1999. But I could not have lived with owning it expecting an acquisition within 3 years.

I just can't see why azn moved to pounce now; it's not the drug program....it has to be the shrinking antibody platform space as you all have suggested.

Cramer must have heard, didn't he tout catg a month or so ago?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News